Screener
Vir Biotechnology, Inc. VIR Other Non-Current Assets
Other Non-Current Assets at other companies
Other financials
Where this comes from
Reported directly by Vir Biotechnology, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherAssets.
The source filing: Vir Biotechnology, Inc.’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 5:20 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-053549
| Line item | June 30,2026 | December 31,2025 |
|---|---|---|
| Operating right-of-use assets | 59,391 | 62,099 |
| Restricted cash and cash equivalents, noncurrent | 6,944 | 6,963 |
| Long-term investments | 475,016 | 314,575 |
| Other assets | 24,647 | 24,699 |
| TOTAL ASSETS | $1,214,806 | $1,002,823 |
| LIABILITIES AND STOCKHOLDERS’ EQUITY | ||
| CURRENT LIABILITIES: | ||
| Accounts payable | $17,754 | $9,803 |
Item 1. Financial Statements (unaudited)
FAQ
- What is Vir Biotechnology, Inc.'s other non-current assets?
- Vir Biotechnology, Inc. (VIR) reported other non-current assets of $24.65M in Q2 2026.
- How has Vir Biotechnology, Inc.'s other non-current assets changed year-over-year?
- Vir Biotechnology, Inc.'s other non-current assets increased by 86.9% year-over-year, from $13.19M to $24.65M.
- What is the long-term trend for Vir Biotechnology, Inc.'s other non-current assets?
- Over 5 years (2020 to 2025), Vir Biotechnology, Inc.'s other non-current assets has grown at a 22.8% compound annual growth rate (CAGR), from $8.83M to $24.7M.
- What does other non-current assets mean?
- Long-term assets not classified in specific categories — a catch-all for miscellaneous non-current assets.
Ask your AI about Vir Biotechnology, Inc.'s other non-current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude